The global enteral feeding devices market size is forecasted to be USD 2.63 billion in 2024 and USD 3.32 billion by 2029, growing at a CAGR of 4.97% between 2024 to 2029.
Enteral feeding devices are essential for people suffering from medical ailments such as swallowing disorders, digestive disorders, neurological disorders, cancer, etc. With the rise in the population's average age globally, there would be more older people than youth, resulting in increased use of these devices. In addition, existing enteral feeding device manufacturers are starting to adopt innovative technology and methods for patient safety. Using unique connection systems to dodge the misconnection of feeding tubes is one method that decreases the difficulties associated with enteral feeding devices. Enteral feeding devices administer enteral nutrition to patients who cannot eat or drink enough to meet their nutritional needs. These devices are commonly used in patients with chronic illnesses or conditions that prevent them from consuming food and liquids orally, such as those with neurological disorders, digestive tract disorders, or recovering from surgery. There are several enteral feeding devices, including nasogastric tubes, gastrostomy tubes, and jejunostomy tubes. These devices are inserted through the nose, mouth, or abdomen and deliver nutrition directly to the stomach or small intestine.
The World Health Organization (WHO) stated that the number of preterm births is significantly growing, and around 15 million preterm births occur annually. Furthermore, the complications associated with preterm births are among the leading causes of death in children under five years. Therefore, the factor mentioned above is expected to boost the growth of the global enteral feeding devices market. Furthermore, the global burden of chronic diseases is increasing with the year passing, and the number of mortalities is increasing yearly. Therefore, the usage of enteral feeding devices is increasing among chronic patients, which is expected to result in market growth. Furthermore, enteral feeding devices are used by a considerable number of people who turned above 60 years of age, further propelling the demand for these devices from this age group and is expected to boost the market's growth rate. According to World Health Organization (WHO), one person in every six is expected to be aging more than 60 years by 2030.
The enteral feeding devices market is also driven by the growing shift towards enteral from parental as it is less intrusive and more consistent. In addition, the rising adoption of enteral feeding devices in ambulatory services and growing R&D activities toward manufacturing effective enteral feeding devices further promote the market's growth rate. Furthermore, the growing adoption of these devices from underdeveloped and developing countries is expected to fuel market growth during the forecast period.
As mentioned by the Centers for Disease Control and Prevention, in the United States, 6 in 10 adults suffer from at least 1, and 4 in 10 adults have two or more chronic diseases. Furthermore, the growing need for enteral nutrition, rising malnutrition cases, and the growing geriatric population are other significant factors that further fuel market growth. In addition, technological advancements in enteral feeding devices that comprise consistent changes among the products to suit the single patient requirements also favor the market.
However, the main factors hindering the market's growth are the lack of public awareness, difficulties associated with using these devices, and reimbursement issues in developing countries. Enteral feeding devices' reimbursement policies are insufficient in countries such as APAC, Latin America, and the Middle East & Africa. These insufficient reimbursement policies pose a significant challenge to the extensive adoption of enteral feeding in these countries.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Covered |
By Product Type, Stage, Application, End-User, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis, Porter's Five Forces Analysis; Competitive Landscape; Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
Market Leaders Profiled |
Halyard Health Inc., C. R. Bard Inc., Abbott Laboratories, Fresenius SE, Covidien PLC, Cook Medical, and Nestle S.A. |
Based on product type, the enteral feeding pumps segment led the market in 2022, with more than half the share going to such products. It is also anticipated to be the fastest-growing among the major five during the forecast period. The segment's dominance is mainly because it is a convenient slow feeding method wherein the patient is slowly administered continuous and direct nutrition, and it is a system that can be performed at home with the help of nurses and caregivers. The system also reduces the number of errors with the feeding system and is a consistent and accurate procedure for the patient's health, making it more favorable. Therefore, the enteral feeding tube segment is considered a lucrative segment and is predicted to register a healthy rate during the forecast period due to the growing adoption of these devices.
However, the enteral feeding pumps segment is also expected to show significant growth during the forecast period due to the increasing preference towards pumps for regular patients. Moreover, in the cases of patients who do not need a continuous nutrition supply and can digest a good amount of nutrition at once, pumps are the best equipment, thus promoting the segment's expansion in recent times.
Based on the stage, the pediatrics segment is forecasted to lead the market during the forecast period due to growing occurrences of preterm births worldwide. In addition, the rising cases of the need for personalized healthcare for child patients with growing diagnoses of chronic illness in the underage patient group are expected to support the expansion of this segment. According to the CDC statistics in the United States, 1 in 15 children and around 27% of children have MCCs. Therefore, the high rates of treatment requirement in children, especially for enteric diseases, is leading the segment growth.
However, the adult segment is also expected to show fast growth during the forecast period due to the rising cases of chronic diseases in adults and the growing geriatric population who need enteric feeding device services.
The oncology segment previously held the largest enteral feeding devices market share based on the application. It is projected to showcase a solid CAGR during the forecast period. Cancer patients tend to use enteral feeding into a vein or stomach. The enteral devices are combined among the patients before their radiotherapy or chemotherapy treatment starts. Proper nutrition acts as an essential role in the treatment of cancer treatments. The food is proficient with enteral feeding devices in patients who cannot absorb the nutrients. Therefore, the high adoption of enteral feeding devices is used to supply clinical nutrients to patients.
The diabetes segment is estimated to witness a robust CAGR during the forecast period due to the rising of patients with diabetes needing the enteral feeding system. The bulk of the approximately 422 million individuals with diabetes globally reside in low- and middle-income nations, and diabetes is directly responsible for 1.5 million fatalities annually. Diabetes is a condition where blood sugar levels need to be steadily maintained, and food intake needs to be watched. This monitoring is supported by the enteral feeding system, further promoting the segment's growth.
Based on end-user, the hospital segment occupied the largest share of the global enteral feeding devices market in 2022 and is anticipated to dominate worldwide during the forecast period. Many hospitals implement enteral nutrition as an efficient clinical nutrition system. Due to the increasing number of hospitals worldwide, the hospital sector is anticipated to dominate the market. Hospitals strive to offer the most satisfactory services possible and have sophisticated infrastructure and extensive connections. Additionally, hospitals experience a considerable increase in patients due to the confidence they gain by having skilled staff and reliable medical facilities. Hospitals, therefore, have the most comprehensive availability of medications and equipment, contributing to the segment's supremacy.
The ambulatory care services segment is also expected to show fast growth due to the recent advancements in the services and the increasing preference towards the same.
The North American enteral feeding devices market led the market in 2023 and is projected to dominate the global market accounting for the highest share during the forecast period. A well-developed healthcare system and increasing adoption of advanced and patient-friendly enteral feeding devices integrated with safety attributes propel the North American market growth. The U.S. market is expected to account for most of the share in the North American region owing to the increasing per capita income, growing incidence of cancer, and rising number of premature births. As per the U.S. Center for Disease Control and Prevention, there is ongoing diabetic population growth, with 12% of the grown-up population scheduled to have the disease. Therefore, the Canadian market is to exhibit prominent growth. Older adults face difficulties in consuming food and medications.
The European enteral feeding devices market accounted for a significant share of the global market in 2023 and is forecasted to hold a considerable share in the worldwide market during the forecast period owing to the growing prevalence of various infections and increasing patient count suffering from chronic diseases. Around 30% of the patients in Europe are malnourished. Primitive approvals of feeding devices and the high adoption of feeding pumps in the region to promote regional market growth. Countries such as the UK, Germany, and France are estimated to play a vital role in the European region and help significantly to account for a substantial share of the global market during the forecast period.
However, the Asia-Pacific enteral feeding devices market is projected to grow the highest among all regions worldwide during the forecast period. The growing healthcare expenditure and rising awareness towards safe feeding products majorly drive the growth of the APAC market. In APAC, the Japanese market is forecasted to account for a significant share of the APAC market during the forecast period due to the growing nutritional problems in the aging population, the increasing number of hospitals, and the rising number of improvements in the healthcare infrastructure.
The Latin American enteral feeding devices market is another lucrative regional market predicted to grow at a promising CAGR between 2024 to 2029. The regional market is strongly driven by the growing number of hospitals and ambulatory care services executing enteral supplements as clinical nutrition. Brazil is expected to be the leading Latin American market, followed by Mexico, Argentina, and Chile.
The Middle East & African enteral feeding devices market accounted for a smaller global share in 2023. However, during the forecast period, the MEA enteral feeding devices market is forecasted to grow steadily.
Companies profiled in this report that play a vital role in the global enteral feeding devices market are Halyard Health Inc., C. R. Bard Inc., Abbott Laboratories, Fresenius SE, Covidien PLC, Cook Medical, and Nestle S.A.
By Product Type:
By Stage
By Application
By End User
By Region
Frequently Asked Questions
The global enteral feeding devices market was worth USD 2.51 billion in 2023.
North America captured the leading share of the worldwide enteral feeding devices market in 2023.
Based on application, the oncology segment accounted for the largest share of the global market in 2023.
Halyard Health Inc., C. R. Bard Inc., Abbott Laboratories, Fresenius SE, Covidien PLC, Cook Medical, and Nestle S.A. are some of the notable players in the enteral feeding devices market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region